Back to All Events

Castle Biosciences - Decision DX: Using 31-GEP to Guide Risk Aligned Management for Melanoma Patients

  • Bellpine 900 SW Washington St. Portland, OR 97205 United States (map)

Join Castle Biosciences for a dinner presentation featuring Jillian Hunt, MSN, APRN, FNP-C, AOCNP discussing the use of 31-GEP to guide management of melanoma. Specializing in cutaneous oncology, Jillian has great examples of the many utilities of genetic testing in melanoma cases and is ready to share her experience with our local dermatology community.

Dinner at Bellpine restaurant is provided.

Please RSVP to Shallee Barbee by October, 6th, 2025, by phone (541-441-1252) or email.

For more information, please see the event flyer.

Previous
Previous
October 11

OSDA Annual CME Conference